HomeBUSINESS
BUSINESS

AstraZeneca’s Japan Crestor Sales Dive 71%
(Aug.3.2018)

AstraZeneca saw its Japan sales of the cholesterol fighter Crestor (rosuvastatin) in January-June plummet 71% year on year (72% on a constant exchange rate basis), dragged down by generic debuts in the second half of 2017 ...
(LOG IN FOR FULL STORY)

Notice

 The next ebook update will be provided on August 20.

News Calendar